AI若能自主复现顶尖科研论文，未来科研将被掀翻天。OpenAI最新框架PaperBench正为此生，让AI智能体从头开始复现ICML 2024 20篇优秀论文，只有Claude 3.5 Sonnet拔得头筹，但仍无法超越ML博士水平。

在人工智能领域，技术革新不断推动行业前行。最近，OpenAI推出新基准测试PaperBench，聚焦于AI智能体在复现ICML2024顶会论文中的表现，以期提升AI的综合能力。根据测试结果，新版Claude-3.5-Sonnet显著超越其他竞争对手， ...

Sonnet's F H AB was designed to specifically target tumor and lymphatic tissue, with an improved therapeutic window for optimizing the safety and efficacy of immune modulating biologic drugs.

Investing.com — Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN)，一家市值389万美元的微型制药公司，在其总裁、CEO和董事长Pankaj Mohan于2025年3月31日去世后宣布了重大领导层变动。根据InvestingPro分析，尽管公司面临重大挑战，股价接近52周低点1.22美元，但该公司似乎被低估。

Some say that the introduction of Claude Sonnet 3.7 marked the beginning of Cursor’s downfall, but that’s just the tip of the ...

PRINCETON, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Shares of SONN opened at $1.34 on Tuesday. Sonnet BioTherapeutics Holdings, Inc.

PRINCETON, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company ...

在科技迅猛发展的今天，人工智能到底能走多远？近日，OpenAI又一次引发了我们对AI前景的深刻思考。当地时间4月2日，美国开放人工智能研究中心（OpenAI）宣布了PaperBench的推出，这个新基准的提出，似乎是对智能体研究能力的一次全新挑战。

(RTTNews) - Sonnet BioTherapeutics Holdings, Inc. (SONN), Tuesday said it has appointed one of its directors Raghu Rao as interim chief executive officer after the company's founder and CEO Pankaj ...

In a new paper, Anthropic researchers tested the “faithfulness” of CoT models’ reasoning by slipping them a cheat sheet and waiting to see if they acknowledged the hint. The researchers wanted to see ...